In association with Gyanshree School, Apollo Hospitals Noida, organized a health camp for Gyanshree School students. It was a commendable initiative aimed at nurturing the well-being of the students – a step towards building a healthier and brighter future for our young minds!

Apollo Hospitals Noida, In association with Paytm organized a health camp for Paytm employees. The camp offered health check-ups, consultations, and emphasized the importance of wellness. A great initiative promoting employee health and well-being.

The pediatric cardiac team at the new Apollo Children’s Hospital, Chennai successfully performed a complicated surgery to treat a condition called complete A-V canal defect in a four-month-old Nigerian baby. Apollo Children’s Hospital, is a one of its kind comprehensive paediatric hospital in the country. A tertiary care multi-speciality hospital, the Apollo Children’s Hospital will administer health care for children from birth to adolescence under one roof. The pediatric cardiac team at the new Apollo Children’s Hospital at Chennai successfully performed a complicated surgery to treat a condition called complete a-v canal defect in a four-month-old Nigerian baby. Speaking at the press briefing alongside the patient, Dr Neville Solomon, pediatric cardiac surgeon and Dr Muthukumaran, pediatric cardiologist said, “”The Nigerian baby was ailing with a condition called complete a-v canal defect. This consists of two holes in the heart with mitral and tricuspid valves possibly leaky as well. The child also has Down’s syndrome, which makes the surgery even more risky. The child was investigated by 2D echo, 3D echo and catheterization and angiogram. The surgery involved closing of the holes in the heart and repairing the mitral and tricuspid valves.”” The preoperative 3D echo was done by Dr Muthukumaran, who is among the few cardiologists in the country trained to perform this investigative procedure. This 3D transesophageal echo at Apollo is the first of its type in Tamil Nadu. Dr Neville Solomon added, “”It is gratifying that the baby was brought in for surgery by the fourth month as usually beyond six months, the results are not as good. It is gratifying that the baby is doing well and will be returning home tomorrow. We have been treating numerous international patients at the hospital.”” Apollo Children’s Hospital, exclusively for children and adolescents up to the age of 16 years, is a one of its kind comprehensive pediatric hospital in the country. A tertiary care multi-specialty hospital, the Apollo Children’s Hospital will administer health care for children from birth to adolescence under one roof. All of the services will be delivered in a child friendly focused environment. The services are designed to meet the physical, social, emotional and psychological needs of every child with well-trained pediatricians of great clinical experience and knowledge. Addressing the gathered media, Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, “”This 80- bedded Apollo Children’s Hospital is emblematic of the change we wanted to see in child healthcare, and an extension of our long and successful foray in quality pediatrics. Every little life represents immense potential and the onus is on us to nurture it.”” Situated in the close vicinity of flagship Apollo Hospitals at Greams Road, The Apollo Children’s Hospital is one of the finest in the country. Complete with an NICU, Isolation ward, three operation theatres, sunshine ward, cheerful private rooms and tasteful suites, the new hospital leaves no stone unturned in providing the best pediatric care. The cardiology team consisting of Pediatric Interventional Cardiologist and the Cardio Thoracic Surgeon are available to tackle highly complicated congenital anomalies and the Pediatric Cardiac Intensive Care Unit looks after these cases pre and post operatively. The department of Pediatric Surgery and Pediatric Urology carries out various procedures on children and neonates including laparoscopic surgery. The other super specialties are Pediatric Neurology-Neuro Surgery Nephrology and Gastroenterology, which are well covered by expert consultants for an accurate diagnosis and proper treatment. The department of Hemato – Oncology gives a new lease of life to the hitherto fatal disease like Aplastic anaemia, Leukaemia and Storage disorders etc., Bone marrow transplants have been done on many children with excellent results. The Neonatal Intensive Care Unit with expert neonatologists take care of premature babies with very low birth weight with good outcome comparable to international standards. Equipped for every pediatric emergency, Apollo Children’s Hospital is geared to care for acute problems and emergencies promptly and efficiently in the ‘golden hours’ for all the emergencies. The emergency and Pediatric Intensive Care Unit (PICU) will be complementary to each other will sole aim to save the precious lives and is functional 24X7. The transport unit consisting of attained registrar level pediatrician, well-trained nurses and paramedical staff are ready to rush to the site of emergencies to pick up the sick babies at Airport, home or even from any other hospitals. They will assess the sick child, stabilize the child and transport the child to our children’s hospital. The doctors, nurses and paramedical staff are well trained in the pre hospital care of these patients. For the sick newborn state of the art Transport Incubators are available for their safety. The PICU is unique as it is headed by the senior consultants well trained in delivery of intensive care.    

Lokomat – The robotic locomotion therapy equipment Armeo – Upper Limb rehabilitation device Erigo – Rehabilitation modality for bed-ridden patients Apollo Hospitals has instituted a contemporary Neuro Rehabilitation Programme at the Main Hospital in Chennai. The first of its kind in India, the innovative therapy will help the neurologically impaired patients immensely. Using the latest in technology, the medical team at Apollo Hospitals will help patients in rehabilitation, as well as their families, live their lives to the fullest. Rehabilitation addresses the prevention and correction of the secondary effects of injury and illness. The rehabilitation equipment has been sourced from Hocoma, based near Zurich, Switzerland is the global leader in robotic rehabilitation therapy for neurological movement disorders. Neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis or other neurological diseases and injuries as well as small children with cerebral palsy can benefit from these neuro rehab programmes. Speaking at the formal inauguration in Chennai, Preetha Reddy, Managing Director, Apollo Hospitals Group said, “”Our patients come to us with immense hope and their loved ones pray that we can work a miracle to help restore normalcy. It has been our constant endeavour to find better and efficient ways to rehabilitate patients with neurological disorders. Ushering in a new hope, Apollo is introducing robotics in neurorehab for the first time in India in association with Hocoma. The latest technology in neuro rehabilitation, it will aid our therapists and patients immensely in the rehabilitation process.”” Participating at the launch, Dr. Gery Colombo, CEO and one of Hocoma’s founders said, “”Hocoma’s primary goal is the improvement of the therapy of neurological patients. We work with leading hospitals, clinics and scientists across the globe to develop rehabilitation devices to increase therapy success and to support physicians and therapists in their daily work. We are honoured to associate with Apollo Hospitals, Asia’s most trusted healthcare provider to offering patients a panacea for their ailment.”” Functional movement and sensory stimulation play an important role in the rehabilitation of neurological patients following stroke, spinal cord injury, traumatic brain injury, as well as in patients with multiple sclerosis or other neurological diseases and injuries. The Lokomat, the robotic locomotion therapy equipment, Armeo, an upper limb rehabilitation device and Erigo, a rehabilitation modality for bed ridden patients have been installed at the Main Apollo Hospital, Chennai Lokomat The Lokomat is a robotic locomotion therapy device, which is used for patients who have had strokes, spine injuries, brain injuries, multiple sclerosis or other neurological disorders. The Lokomat combines a robotic gait orthosis and an advanced body weight support system with a treadmill. The therapy involves “”task specific learning”” with continuous repetition of movements, based on neuroplasticity. Training sessions are longer and more intensive than manual treadmill training, helping accelerate progress. The Lokomat has robotic arms for adult and paediatric patients. These robotic arms move the paralyzed hips and knees in a pre-programmed way to simulate normal walking, on an automated treadmill, at an adjustable speed. It provides improved patient motivation through visualized performance feedback with assessment tools Armeo Designed for upper limb re-training, the Armeo enables patients to perform exercises that simulate everyday activities, with the use of an adjustable arm support and a highly sensitive handgrip. It can be used for patients who have had strokes, brain injuries or other neurological disorders. The Armeo software captures joint angles and hand path, helping the therapist assess the patient’s co-ordination process and progress accurately. Armeo can be customized for individual patients. It offers a large 3-D workspace that allows functional therapy exercises in a virtual reality environment Erigo The Erigo accelerates early rehabilitation of debilitated and neurologically impaired patients. Treatment with the Erigo includes verticalisation, leg movement and loading. The device consists of a continuously adjustable tilt table with a robotic stepping mechanism. The stimulation of nerve endings and facilitation of free flow of blood to the brain helps prevent drop in blood pressure level, which can occur when conventional tilt tables are used. The cyclical limb loading promotes wakefulness. Patients with any neurological condition resulting in inability to walk or use the arm viz. traumatic brain injury, spine injury, Multiple Sclerosis, Cerebral Palsy, Parkinson’s Disease and so on would benefit from this innovative neuro rehabilitation programmes.  

Steering a paradigm shift in cancer care, Apollo Speciality Cancer Hospital, Chennai recently installed Asia Pacific’s most advanced and India’s first CyberKnife®. “The CyberKnife® at Apollo Speciality Cancer Hospital, Chennai is now set to offer treatment access to millions of patients diagnosed with cancer in India every year. We are working towards a goal of making all types of cancer curable, said Dr. Prathap C Reddy, Executive Chairman, Apollo Hospitals Group during the clinical inauguration of the CyberKnife, initiated with Prof. Dr. John Adler consulting the first patient scheduled to undergo treatment.”” He added, “”It is a rare opportunity to host a genius like Prof. Dr. John R Adler, renowned as the “”Father of the CyberKnife”” at our hospital. With the launch of CyberKnife®, Apollo Speciality Cancer Hospital joins the global league of hospitals equipped to provide 360-degree cancer care.”” Developed by Prof. Dr. John.R.Adler M.D, Professor of Neurosurgery and Radiation Oncology at Stanford University Medical Centre, CA, U.S.A, the CyberKnife® Robotic Radiosurgery System is the first system in the world designed to treat tumors anywhere in the body with sub-millimeter accuracy. After consulting the first patient scheduled for CyberKnife treatment, Prof. Dr. John Adler said, “”Dr. Prathap C Reddy’s commitment to cancer care is a beacon of hope to millions battling with cancer in India. Over 60,000 patients have benefited from the CyberKnife treatment across the world. The technological advancement that the Apollo CyberKnife Radiosurgery offers is that it can treat any brain tumour in less than 16 minutes and a body tumour within 30 minutes with 3-5 treatment sessions.” The advanced technology behind CyberKnife® uses real time image guidance technology and computer-controlled robotics to deliver an extremely precise dose of radiation to targets, avoiding the surrounding healthy tissue and adjusting for patient and tumor movement during treatment. Benefits to Patients A new treatment option: This extraordinary sophisticated treatment can be used as an alternative to open surgery Occasionally CyberKnife® treatment even can convert a technically inoperable tumor to operable. Pain free: treatment does not cause pain and therefore does not require anesthesia. Recovery Time: Vast majority of CyberKnife® treatments are out patient procedures allowing patients to continue their activities. Comparative comfort: Many of the available high precision radiation techniques require application of some kind of frame around patient’s body, CyberKnife® can spare the particular inconvenience for the patient. In many of the cases, it is a frameless procedure. CyberKnife® can treat by organ and by tumor targets located anywhere in the body and is a revolution in the treatment of cancerous and non-cancerous tumors in the body, including the prostate, lung, brain, spine, liver, pancreas and kidney.All patients who will undergo the CyberKnife® treatment will go through the Apollo CyberKnife® Advisory Board. Address Apollo Speciality Cancer HospitalNew.No.6 (Old.No.24) Cenotaph Road, Teynampet, Chennai – 600 035Contact Ms. Lakshmi: Mobile: +91 9941056677 I Tel: +91 -44-24334455 SMS Apollo to 56677 I Email: cyberknife@apollohospitals.com

Apollo Hospitals, Chennai, has set a new standard in complex cardiac care by successfully treating two high-risk coronary cases. Leveraging the advanced CHIP (Complex High-Risk Indicated Procedure) technique and ELCA (Excimer Laser Coronary Angioplasty), the institution reaffirms its leadership in addressing complex coronary blockages with precision, innovation, and patient-centric expertise.   The team reopened a completely occluded 12-year-old stent using laser angioplasty, restoring blood flow in a challenging, long-standing blockage. In the second case, a 15-year-old stent with severe restenosis and an ejection fraction of just 30 percent required a tailored, high-risk intervention. Supported by IABP (Intra-Aortic Balloon Pump) and ELCA laser therapy, the team successfully cleared the blockage and placed a new-generation stent. Both patients made excellent recoveries and were discharged within 48 hours.  These procedures were led by Dr. Refai Showkathali, Senior Consultant and Interventional Cardiologist at Apollo Hospitals, Greams Road, Chennai, along with the skilled Cath Lab team. Apollo Hospitals also expressed appreciation for the expert insights contributed by Dr. Jaswindar Singh from Washington during the interventions. With each such breakthrough, Apollo Chennai continues to enhance outcomes for patients with complex coronary disease, setting new benchmarks in advanced interventional cardiology. 

Apollo Hospitals, Chennai, has achieved a new landmark in the care and management of heart diseases with the introduction of the advanced PLS Excimer Laser System. The workshop, conducted by Dr. G Sengottuvelu, Interventional Cardiologist, Apollo Hospitals, Chennai, assisted by Dr. Jaswindar Singh from Washington University, USA, displayed the unique capabilities of the Excimer Laser in managing complex coronary blockages where conventional angioplasty generally fails.  PLS Excimer Laser therapy applies brief, gentle bursts of ultraviolet light to vaporise plaque with minimal effect on surrounding tissue. It strengthens cardiac intervention by allowing treatment of cases in a far safer manner with greater accuracy. Examples of challenging cases include chronic total occlusions, heavily thrombotic lesions, stent failures, calcified and fibrotic vessels, occluded grafts, and even the extraction of pacemaker leads  Patients benefit from improved outcomes, reduced vessel damage, and versatile care for complex cardiac scenarios. Advantages include increased safety, higher intervention accuracy within calcified or fibrotic lesions, and the expansion of treatment options in failed stents and blocked grafts.  Under the expert leadership of Dr. Sengottuvelu, Apollo Hospitals continues to drive cardiac innovations forward, reinforcing its standing for world-class care and clinical excellence.  

Hospitals in Chennai are deploying AI-powered scan systems that detects possible stroke symptoms to radiologists within minutes, much before human review. A stroke occurs when the blood supply to the brain is interrupted or reduced, depriving the brain tissue of oxygen and nutrients. AI-driven scans now generate a “severity score” that computes stroke intensity and helps doctors initiate quicker action with intravenous thrombolysis within 4½ hours or mechanical thrombectomy within 6½ hours for timely and appropriate treatment.  According to Dr. Ilankumaran Kaliamoorthy, CEO of Apollo Hospitals, Chennai region, the integration of AI has cut the time taken from scan to interpretation from about 30 minutes to just 7 minutes.  Neuro-endovascular surgeon Dr. Srinivasan Paramasivan at Apollo Hospitals, Chennai shared that with stroke, each lost minute destroys 12 km of nerve fibres. Therefore, diagnostic speed is the key. Thanks to AI-powered technology, identification and management of stroke now happens in minutes.  Dr. Satish Kumar, a Neurologist at Apollo Hospitals, added that the AI tool quickly assesses the severity of stroke and flags blocked arteries to help even general radiologists make quicker and more assured decisions, especially in places where specialists may not be immediately available.  While AI is changing healthcare, clinicians who have adapted to it will eventually take precedence over those who have not, as it influences diagnostic capabilities and speed, said Dr. N. Sridhar, Consultant Intensivist at Kauvery Hospital.  However, Dr. C. Amarnath, Head of Radiology at Government Stanley Hospital, said AI improves precision and turnaround, but added costs involved in need to be carefully weighed — especially in large urban centres with specialist staff.  Overall, AI integration in stroke imaging constitutes a major leap in acute care — faster diagnosis, timely treatment, and better outcomes. This is set to expand the adoption of AI-powered software at peripheral and rural hospitals, translating into better equitable emergency care across India. 

Apollo Hospitals Group, India’s largest integrated healthcare provider today unveiled the ZAP-X Gyroscopic Radiosurgery Platform, a revolutionary advancement in brain tumor treatment, marking a significant milestone as the first in South Asia to introduce this ground-breaking technology. With ZAP-X, Apollo Hospitals continues its legacy of innovation and commitment to providing world-class healthcare solutions for patients in India and across the world. ZAP-X introduces a new era in brain tumor treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes. This transformative technology redefines precision with minimal radiation exposure, enabling new standards in effectiveness and patient comfort. Unlike conventional methods, ZAP-X utilizes a self-shielded, gyroscopic linear accelerator design, to direct radiosurgical beams from thousands of potential angles, accurately focusing radiation on the intended tumor or target. This innovative method improves patient outcomes by enhancing the ability to avoid critical structures like the brain stem, eyes, and optic nerves, while also drastically minimizing exposure to healthy brain tissue to safeguard a patient’s cognitive function. ZAP-X’s proven clinical capabilities will enable neurologists and neurosurgeons in treating Primary & Metastatic Brain tumors, Arteriovenous Malformations (AVMs), Trigeminal Neuralgias, Movement Disorders such as Parkinson’s disease, Epilepsy and other intracranial lesions such as meningiomas, acoustic neuromas and pituitary adenomas, with better accuracy and fewer side effects to patients. Dr Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group said at the launch: “For more than four decades, Apollo Hospitals has been at the forefront of healthcare, continuously challenging limits to provide exceptional care. Upholding this tradition, we have unveiled ZAP-X, an innovative technology designed for the treatment of brain tumors. This new approach allows for non-invasive, pain-free sessions lasting 30 minutes, with minimal exposure to radiation. ZAP-X also comes with advanced safety protocols, including instant error detection and reduced radiation leakage, that ensure the patient’s well-being and quality of life post treatment. Furthermore, as an outpatient procedure it allows for greater convenience and accessibility for patients. We commit to ensure that this technology is made available for every citizen of our country and for people across geographies, as this will be a boon for how brain tumors are approached and treated. With the rising tide of Non-Communicable Diseases (NCDs), ZAP-X will be a new addition in our fight against NCDs, of whom cancers, form a significant portion.” The ZAP-X technology comes with key advantages which include it being non-invasive, thereby not requiring a surgical intervention for certain brain tumors, is pain-free; and offers frameless, pinpoint accuracy and real-time image guidance for shorter treatment durations and enhanced patient safety. ZAP-X demonstrates high success, ensuring effective control and relief for various conditions with minimal side effects. It achieves over 95% control rate in 10 years with minimal facial or trigeminal side effects. ZAP-X shows an exceptional 99.4% control rate in 5 years for small, defined tumors.Prof. John R. Adler, Founder and CEO, Zap Surgical and Professor of Neurosurgery, Stanford School of Medicine said, “Stereotactic radiosurgery is among the most important medical advancements of the past century. Eligible patients no longer must experience debilitating surgical resections, or potentially lose cognitive capacity by undergoing whole-brain radiotherapy. Instead, with ZAP-X radiosurgery, patients can now be quickly treated in an outpatient setting and often return to normal activities the same day with no incisions, and no pain.” While traditional brain surgeries last 3-4 hours, ZAP-X completes treatment within a single session lasting no more than 30 minutes. ZAP-X allows for a day-care procedure, enabling patients to return home post-treatment, unlike traditional surgeries requiring 4-7 days or more of hospitalization, and without the necessity of anesthesia. The Apollo Institute of Neurosciences stands as a pioneering force in revolutionizing neurological care across India and the region. With state-of-the-art facilities, including emergency services, neuro-ICUs, and rehabilitation centers, Apollo has achieved a remarkable milestone of over 180,000 successful neurosurgeries. Leveraging cutting-edge AI technology, the Institute has redefined stroke protocols, enabling swifter, more accurate diagnosis and treatment. Backed by a formidable team of over 300 neurosurgeons and neurologists, Apollo treats more than 25,000 patients annually, performing nearly 6,000 brain and spinal surgeries. This exceptional volume solidifies Apollo’s expertise in managing even the rarest and most complex neurological cases, attracting patients from around the world seeking unparalleled care. The unveiling of the ZAP-X platform reaffirms Apollo’s commitment to spearheading innovations that transform lives.

Apollo Knowledge, a leader in global healthcare training and workforce development, has launched a one-year, full-time Advanced Certification in Genomics (ACG) program in collaboration with the Sri Ramachandra Institute of Higher Education and Research (SRIHER) in Chennai. The initiative marks a major milestone for Apollo’s Global Workforce Development (GWD) program, which is designed to build a strong pipeline of genomics-trained clinical scientists for international healthcare systems. Launched in August 2025, the ACG program currently hosts 37 postgraduate students (M.Sc./M.Tech.) from diverse life sciences backgrounds. Modelled on the NHS England curriculum, it offers comprehensive learning in genetic testing, cancer genomics, bioinformatics and genetic counselling, supported by advanced laboratory and clinical exposure. In addition to scientific training, learners receive English language coaching, soft-skills development, and interview preparation to support international mobility. The program was formally inaugurated on 18 November 2025 in the presence of senior leaders from SRIHER, Apollo Knowledge and experts associated with the NHS. During the event, Prof. Dame Sue Hill, Chief Scientific Officer for England and the Head of Profession for healthcare science workforce in the NHS and associated bodies, highlighted that the partnership showcases how countries can work together to build the skilled workforce needed to advance genomic medicine. Mr Sivaramakrishnan Venkateswaran, CEO of Apollo Knowledge, emphasised that the collaboration strengthens Apollo Knowledge’s mission under its Global Workforce Development (GWD) initiative — equipping healthcare professionals with advanced technical, language and soft skills to pursue international careers, in line with India’s ‘Heal by India’ vision. 

Apollo Hospitals has announced the opening of its new 250-bed quaternary care hospital in Swargate, Pune on November 24, 2025. This is a major step in expanding world-class healthcare access across western India. The facility is part of a phased development plan and will scale up to 400 beds to support the growing healthcare needs of the region.(From left to right) Dr Madhu Sasidhar, Dr Suneeta Reddy, Dr Preetha Reddy, Mr. Arunesh Punetha and Dr Manisha Karmarkar at a press conference to announce the unveiling of Apollo Pune.The hospital features next-generation medical infrastructure, including modular operating theatres, advanced robotic surgical systems such as the Da Vinci Xi and Mako, and comprehensive critical care units with over 100 critical care beds. The centre offers highly specialised services across cardiac sciences, oncology, organ transplants, orthopaedics, and mother-and-child care. Dedicated neonatal and paediatric ICUs with IoT-enabled monitoring and telemedicine integration ensure enhanced safety and clinical responsiveness for young patients. Commenting on the launch, Dr. Prathap C Reddy, Founder-Chairman, Apollo Hospitals Group, said that Apollo’s mission is to transform healthcare for India and the world, guided by the “Heal in India – Heal by India” vision, and to bring clinical excellence with compassion and affordability to every home. Dr. Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise Ltd., noted that the Pune hospital is a strategic addition to Apollo’s national expansion, strengthening access to high-end quaternary care and integrated healthcare network for Maharashtra. Built on Apollo’s unified digital ecosystem, the Pune facility enables seamless patient navigation from primary consultations to super-specialty and critical care through structured referral pathways. The hospital reinforces Apollo’s commitment to delivering compassionate, evidence-based, and accessible care for the city’s rapidly growing urban population.  

Apollo Hospitals have entered a partnership with Coal India Limited to provide quality healthcare services to more than 2.5 lakh employees, 5 lakh pensioners, and their families across the country. This historic partnership aims at improving access to quality health services by providing comprehensive medical treatment, along with preventive health programs, through Apollo's 44 hospitals across the country.  A Memorandum of Understanding (MoU) to this effect was signed in Chennai in the presence of Dr. Prathap C. Reddy, Chairman, Apollo Hospitals and Dr. Vinay Ranjan, Director (HR), Coal India Limited. Senior officials from Coal India and Apollo Hospitals were also present on the occasion. The tie-up is in line with Coal India's belief in the welfare of its workforce, which powers nearly 70% of the country's energy requirements. For employees and retirees, medical treatment on tariff basis replaces the earlier payments on the CGHS rate, ensuring easier accessibility and better affordability. Cashless medical treatment is provided through an integrated referral and billing process between Apollo Hospitals and the medical departments of Coal India. Beyond treatment, the initiative emphasises preventive health screenings and community wellness programs designed to improve workforce productivity and protect the well-being of coal workers and their families. This partnership is a great example of industrial leadership combined with social responsibility, integrating Swachh Bharat with Viksit Bharat.